Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

作者: Yoshihiro Ohue , Hiroyoshi Nishikawa

DOI: 10.1111/CAS.14069

关键词: CD86CD80Cytotoxic T cellTumor microenvironmentImmune systemIL-2 receptorImmune checkpointCancer researchCancer immunotherapyBiology

摘要: … Treg cells is associated with poor survival in various types of cancer. Therefore, strategies to deplete Treg cells and control of Treg … of Treg cells in cancer and the development of Treg …

参考文章(82)
Craig L. Bennett, Jacinda Christie, Fred Ramsdell, Mary E. Brunkow, Polly J. Ferguson, Luke Whitesell, Thaddeus E. Kelly, Frank T. Saulsbury, Phillip F. Chance, Hans D. Ochs, The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genetics. ,vol. 27, pp. 20- 21 ,(2001) , 10.1038/83713
Makoto Miyara, Driss Chader, Edouard Sage, Daisuke Sugiyama, Hiroyoshi Nishikawa, Diane Bouvry, Laetitia Claër, Ravi Hingorani, Robert Balderas, Jurg Rohrer, Noel Warner, Alain Chapelier, Dominique Valeyre, Reiji Kannagi, Shimon Sakaguchi, Zahir Amoura, Guy Gorochov, Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3high regulatory T cells in humans Proceedings of the National Academy of Sciences of the United States of America. ,vol. 112, pp. 7225- 7230 ,(2015) , 10.1073/PNAS.1508224112
Daniel T. Patton, Oliver A. Garden, Wayne P. Pearce, Louise E. Clough, Clare R. Monk, Eva Leung, Wendy C. Rowan, Sara Sancho, Lucy S. K. Walker, Bart Vanhaesebroeck, Klaus Okkenhaug, Cutting edge: The phosphoinositide 3-kinase p110 delta is critical for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells Journal of Immunology. ,vol. 177, pp. 6598- 6602 ,(2006) , 10.4049/JIMMUNOL.177.10.6598
Y. Ishida, Y. Agata, K. Shibahara, T. Honjo, Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. The EMBO Journal. ,vol. 11, pp. 3887- 3895 ,(1992) , 10.1002/J.1460-2075.1992.TB05481.X
Chen Dong, Amy E. Juedes, Ulla-Angela Temann, Sujan Shresta, James P. Allison, Nancy H. Ruddle, Richard A. Flavell, ICOS co-stimulatory receptor is essential for T-cell activation and function Nature. ,vol. 409, pp. 97- 101 ,(2001) , 10.1038/35051100
Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Bryan Paeper, Lisa B. Clark, Sue-Ann Yasayko, J. Erby Wilkinson, David Galas, Steven F. Ziegler, Fred Ramsdell, Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genetics. ,vol. 27, pp. 68- 73 ,(2001) , 10.1038/83784
Bertus Eksteen, Alice Miles, Stuart M. Curbishley, Chris Tselepis, Allister J. Grant, Lucy S. K. Walker, David H. Adams, Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. Journal of Immunology. ,vol. 177, pp. 593- 603 ,(2006) , 10.4049/JIMMUNOL.177.1.593
Yuka Maeda, Hiroyoshi Nishikawa, Daisuke Sugiyama, Danbee Ha, Masahide Hamaguchi, Takuro Saito, Megumi Nishioka, James B. Wing, Dennis Adeegbe, Ichiro Katayama, Shimon Sakaguchi, Detection of self-reactive CD8+ T cells with an anergic phenotype in healthy individuals Science. ,vol. 346, pp. 1536- 1540 ,(2014) , 10.1126/SCIENCE.AAA1292
Catherine Uyttenhove, Luc Pilotte, Ivan Théate, Vincent Stroobant, Didier Colau, Nicolas Parmentier, Thierry Boon, Benoît J Van den Eynde, None, Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase Nature Medicine. ,vol. 9, pp. 1269- 1274 ,(2003) , 10.1038/NM934
A. J. Rech, R. Mick, S. Martin, A. Recio, N. A. Aqui, D. J. Powell, T. A. Colligon, J. A. Trosko, L. I. Leinbach, C. H. Pletcher, C. K. Tweed, A. DeMichele, K. R. Fox, S. M. Domchek, J. L. Riley, R. H. Vonderheide, CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients Science Translational Medicine. ,vol. 4, ,(2012) , 10.1126/SCITRANSLMED.3003330